ISI modified its price target on Celgene CELG to $67. At the same time, the rating agency left its price target on United Therapeutics UTHR unchanged at $65. On Friday, Celgene lost 1.1% of its value to finish the week at $59.30, while UTHR rose 1.07% to end the day at $57.38.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
